Please login to the form below

Not currently logged in
Email:
Password:

Creabilis

This page shows the latest Creabilis news and features for those working in and with pharma, biotech and healthcare.

UK biotech gains further £47.2m from Biomedical Catalyst funding

UK biotech gains further £47.2m from Biomedical Catalyst funding

For example, clinical-stage biotech company Creabilis leveraged additional capital alongside its award to fund a large clinical trial in atopic dermatitis.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2016 Deal Watch December 2016

    175. Creabilis (UK). Sienna. Acquisition. Portfolio of first-in-class topical. 150. Global rights unless stated. ... Deal structure. Comments. Creabilis. Sienna Biopharmaceuticals. $150m. Undisclosed upfront payments. Regulatory and commercial milestone

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics